^{_{Welcome to the TraderTV Live Morning Research Note. Here's what's making major moves in the market today.}}

0830 - CPI m/m for March 2026: Expected 0.9%; Prior 0.3%
0830 - CPI y/y for March 2026: Expected 3.4%; Prior 2.4%
0830 - Core CPI m/m for March 2026: Expected 0.3%; Prior 0.2%
0830 - CPI y/y for March 2026: Expected 2.7%; Prior 2.5%
1000 - UMich consumer sentiment for April: Expected 51.5; Prior 53.3
1000 - UMich 5-year inflation expectations for April: Expected 3.5%; Prior 3.3%
1000 - Factory orders m/m for February: Expected -0.2%; Prior 0.1%

Taiwan Semiconductor Manufacturing Co Ltd (TSM)

+2.30%

Trading higher premarket after sharing its Q1 2026 revenue, which hit a quarterly record of $35.6 billion. This figure beat estimates of $35.3 billion and represented 35% year-over-year growth. Taiwan Semi also reported March revenue of $13 billion, growing by 45.2% year-over-year and expanding by 31% month-over-month. Aletheia Capital raised its price target on the stock from $500 to $600, citing increasingly aggressive capacity expansion that could drive strong revenue acceleration and potentially triple earnings by 2028.

CoreWeave (CRWV)

+5.65%

Gapping up after Bloomberg reported that Anthropic has signed a multiyear agreement with the company to rent data center capacity to support rising demand for its Claude AI models. The deal includes access to multiple Nvidia chip architectures across US data centers. This report comes just one day after CoreWeave’s announcement of a $21 billion AI cloud capacity agreement with Meta.

Apple Inc (AAPL)

-0.09%

Data from Counterpoint Research’s Market Monitor indicates that the company led the global smartphone in Q1 2026, the first time Apple has done so in any Q1 period. The company’s total market share came in at 21%, indicating 5% year-over-year growth amid demand for its iPhone 17 product. Overall global smartphone shipments declined by 6% on a year-over-year basis, a move that has been attributed in part to DRAM and NAND shortages.

Oil and Energy Stocks

-1.05%

On watch amid continued tensions in the Middle East, with US President Donald Trump expressing displeasure with Iran’s handling of the Strait of Hormuz. In a Truth Social post shared on Thursday evening, Trump said that Iran “better not” be charging fees to tankers attempting to pass through the Strait of Hormuz. Later in the evening, Trump posted that Iran is doing a “very poor” and “dishonorable” job of allowing oil through the Strait and said the country was not upholding their two-week ceasefire agreement.

USO, OXY, XOM, CVX, DVN, COP, EONR, BATL, TPET

Lumentum Holdings Inc (LITE)

+5.10%

Aletheia Capital raised its price target on the stock from $500 to $1,225, forecasting earnings could quadruple from 2026 to 2028 driven by strong revenue growth and significant margin expansion. The outlook is supported by surging demand for EML lasers, dominant market share in 200Gbps components, and rapid scaling of OCS sales, positioning Lumentum as a leading beneficiary of the AI supply chain. Additionally, CEO Mike Hurlston indicated that that the company is set to fill its order book through 2028 due to strong demand.

Meta Platforms Inc (META)

+0.63%

The company is reorganizing by shifting top engineers into a new AI engineering group, as per an internal memo cited by Reuters. This shift comes amid broader workforce changes at the company ahead of expected layoffs. Separately, Meta said it is removing ads on Facebook and Instagram that sought to recruit plaintiffs for lawsuits alleging its platforms are addictive to young users.

Nike Inc (NKE)

-0.30%

Piper Sandler downgraded the stock from Overweight to Neutral and cut its price target from $60 to $50, citing concerns that growth in running will normalize and athleisure demand is becoming saturated across the industry. The firm also flagged limited innovation, lack of new leadership perspective, and an unattractive valuation without near-term catalysts.

ServiceNow Inc (NOW)

-1.35%

Trading lower premarket after UBS downgraded the stock to Neutral and cut its price target to $100, citing reduced confidence in its AI advantage and increasing signs of budget pressure in non-AI software spending. The firm now expects weaker upside, including smaller earnings beats and slower growth in subscription revenue and remaining performance obligations through 2026.

Amazon.com Inc (AMZN)

+0.30%

The stock rallied throughout Thursday’s session, gaining more than 5% on the day and closing near session highs, after CEO Andy Jassy disclosed the company’s $15 billion AI revenue run rate in his annual shareholder letter. During Thursday’s session, Amazon also announced a $25 billion investment in data centers in Mississippi. The company said that this initiative will lead to the creation of 2,000 jobs in the state.

Major Banks

-0.22%

Reuters reported that US Treasury Secretary Scott Bessent and Fed Chair Jerome Powell met with major bank CEOs to warn about cybersecurity risks tied to Anthropic’s new Mythos AI model. Mythos, which is reportedly capable of identifying and exploiting system vulnerabilities, has not been broadly released due to security concerns. The report suggested that officials urged banks to strengthen defenses as access is currently limited to select tech firms. A number of financial institutions, including some of the largest US banks, are scheduled to report earnings next week.

JPM, GS, BAC, C, WFC, MS

Novo Nordisk A/S (NVO)

+1.64%

Trading higher premarket after data from intelligence firm Pharmarack indicated that rival Eli Lilly lost GLP-1 weight-loss drug market share in India. Lilly’s market share in the country dropped from 61% to 56% for the month of March, while Novo Nordisk’s market share held steady at 25% despite a surge of lower-cost generics. The decline in Lilly’s market share follows the expiration of semaglutide’s patent, which is expected to further pressure Lilly’s higher-priced tirzepatide drugs as competition intensifies.

iSpecimen Inc (ISPC)

+69.55%

Gapping up after unveiling a direct shipping model that sends human biospecimens straight from suppliers to customers, bypassing central hubs. The change cuts domestic delivery times from up to 7–14 days to 1–2 days, reduces costs, and is supported by expanded international sourcing partnerships in Europe and Eastern Europe. iSpecimen, which has rallied in the past, has a market capitalization of $3.86 million and a short float of approximately 10.4%.